Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Does the ocular hypertension need treatment].

M Călugăru, D Călugăru

    Oftalmologia (Bucharest, Romania : 1990)
    |June 16, 2006
    PubMed
    Summary

    Ocular hypertension can progress to primary open-angle glaucoma, especially in older individuals with high intraocular pressure and specific corneal and optic nerve characteristics. Most patients do not require immediate treatment but close monitoring for glaucoma progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Frustrated charge density wave and quasi-long-range bond-orientational order in the magnetic kagome FeGe.

    Nature communications·2025
    Same author

    Softening of a flat phonon mode in the kagome ScV<sub>6</sub>Sn<sub>6</sub>.

    Nature communications·2023
    Same author

    Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

    Eye (London, England)·2017
    Same author

    Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.

    Eye (London, England)·2016
    Same author

    Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.

    Eye (London, England)·2016
    Same author

    Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'.

    Eye (London, England)·2016

    Area of Science:

    • Ophthalmology
    • Glaucoma Research
    • Ocular Hypertension Management

    Context:

    • Ocular hypertension is a precursor to primary open-angle glaucoma.
    • Identifying individuals at high risk for conversion is crucial for timely intervention.
    • Current understanding of risk factors guides clinical decision-making.

    Purpose:

    • To review and synthesize the key risk factors associated with the conversion of ocular hypertension to primary open-angle glaucoma.
    • To delineate criteria for initiating therapy versus monitoring in patients with ocular hypertension.

    Summary:

    • Advanced age, elevated intraocular pressure, thin central corneal thickness, and increased vertical/horizontal cup/disc ratios are significant risk factors for glaucoma conversion.
    • Immediate therapy is recommended for patients with moderate to high conversion risk (approximately 10% of cases).
    • For the majority of patients (over 90%) lacking these risk factors, treatment is not necessary, and regular monitoring is advised.

    Impact:

    • Facilitates personalized treatment strategies for ocular hypertension.
    • Reduces unnecessary treatment in low-risk patients, minimizing potential side effects and healthcare costs.
    • Enhances patient outcomes by ensuring timely intervention for those most likely to develop primary open-angle glaucoma.

    Related Experiment Videos